The above mechanisms contribute to the growth of ovarian cancer cells, increase the invasive potential of these cells, and enhance the secretion of angiogenesis markers, e.g., vascular epithelial growth factor (VEGF) and matrix metalloproteinase 2 (MMP-2) by the tumor cells. The gene discussed is MMP2; the disease is ovarian cancer.